Today: 11 June 2026
Browse Category

NASDAQ:IXHL 4 December 2025 - 15 December 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare shares traded near $0.42 early December 15, 2025, after the FDA granted Fast Track designation to its lead sleep apnea drug IHL-42X on December 3. The company also received a Nasdaq bid-price compliance extension to April 2026 and saw updated research coverage from Stonegate Capital Partners in November. Analyst coverage remains limited.
15 December 2025
·

Stock Market Today

  • Renesas Electronics Shares Overvalued After Strong Gains and Recent Pullback
    June 11, 2026, 8:03 AM EDT. Renesas Electronics (TSE:6723) shares fell over the past week despite delivering a 92.49% year-to-date return and a 121.39% total shareholder return over one year. Analysts place the stock 22.7% overvalued, with a consensus fair value of ¥3,489 versus a recent close at ¥4,283. The valuation reflects expectations for a sharp shift from losses to profits, steady revenue growth, and a revised earnings multiple. However, risks include potential trade tensions and demand softness impacting margins. Analyst price targets vary widely from ¥2,000 to ¥4,900, highlighting uncertainty. Investors are advised to weigh the potential rewards against key risks before positioning.

Latest articles

CCH Holdings (CCHH) jumps with Nasdaq $1 bid rule deadline close

CCH Holdings (CCHH) jumps with Nasdaq $1 bid rule deadline close

11 June 2026
CCH Holdings soared 136.99% to $0.82 in premarket trading after being flagged as a top U.S. mover, pulling the Malaysian hotpot chain closer to Nasdaq’s $1 minimum bid requirement ahead of its August 3 deadline, despite no new earnings or business catalyst and recent financial losses, raising questions about the rally’s sustainability.
SpaceX IPO: SPCX $135 Listing Meets $250 Billion Demand

SpaceX IPO: SPCX $135 Listing Meets $250 Billion Demand

11 June 2026
SpaceX’s $75 billion IPO is over three times oversubscribed with $250 billion in investor demand, setting a $135-a-share price for a potential $1.75 trillion valuation, but 2025’s $4.94 billion net loss and a 94x price-to-sales ratio highlight risks as investors weigh Starlink growth against heavy AI and rocket spending.
Go toTop